Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1983 Oct 1;158(4):1211–1226. doi: 10.1084/jem.158.4.1211

Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein

PMCID: PMC2187365  PMID: 6619734

Abstract

We have shown that serum levels of a molecule immunochemically similar to eosinophil granule major basic protein (MBP) are elevated in pregnant women throughout gestation. MBP levels increase during gestation and plateau at approximately 7,500 ng/ml by the 20th wk (greater than 10-fold above normal). Levels return to normal after delivery, with a T1/2 of 13.7 d. The MBP in pregnancy serum is remarkably similar to the eosinophil granule MBP in that: (a) pregnancy MBP fully inhibits the binding of radiolabeled MBP standard in a double antibody radioimmunoassay; (b) this inhibition reaction is specific for human MBP because pregnancy serum produces no inhibition of the binding of radiolabeled guinea pig MBP in the guinea pig MBP radioimmunoassay; (c) in a two-site immunoradiometric assay for MBP, slopes of dose- response curves for pregnancy serum, purified MBP, and serum from a patient with hypereosinophilic syndrome are identical, and maximal binding is comparable; (d) reduction and alkylation of pregnancy sera increases measured MBP 100-fold, as previously shown for eosinophil granule MBP in serum; and (e) the MBP in pregnancy serum demonstrates the same pattern of heat lability as has been previously reported for MBP. Four observations have raised the possibility that the eosinophil is not the source of the MBP in pregnancy serum: (a) no correlation between serum MBP level and peripheral blood eosinophil count exists in pregnant women, in contrast to previous studies of patients with eosinophilia; (b) levels of three other eosinophil-associated proteins are normal or low in pregnancy sera, whereas the serum levels of these proteins are elevated in patients with eosinophilia; (c) the slopes of dose-response curves for pregnancy sera and MBP standards differ in the double antibody radioimmunoassay; and (d) the molecule in pregnancy serum elutes from Sephadex G-50 columns at the void volume, while eosinophil granule MBP and the MBP in serum of patients with eosinophilia elute at a volume consistent with the previously established molecular weight of 9,300. These findings suggest that the MBP in pregnancy serum is derived from a source other than the eosinophil.

Full Text

The Full Text of this article is available as a PDF (939.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman S. J., Gleich G. J., Weller P. F., Ottesen E. A. Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis. J Immunol. 1981 Sep;127(3):1093–1098. [PubMed] [Google Scholar]
  2. Ackerman S. J., Loegering D. A., Gleich G. J. The human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay. J Immunol. 1980 Nov;125(5):2118–2126. [PubMed] [Google Scholar]
  3. BJERSING L., BORGLIN N. E. EFFECT OF HORMONES ON INCIDENCE OF UTERINE ESOSINOPHILIA IN RATS. Acta Pathol Microbiol Scand. 1964;60:27–35. doi: 10.1111/apm.1964.60.1.27. [DOI] [PubMed] [Google Scholar]
  4. Baker A. P., Bergman F., Paul K. G. Studies of eosinophil granulocytes. 3. Steroid hormones and number of eosinophils in the uterus of the mouse and rat. Acta Endocrinol (Copenh) 1967 Apr;54(4):696–706. [PubMed] [Google Scholar]
  5. Bale W. F., Helmkamp R. W., Davis T. P., Izzo M. J., Goodland R. L., Contreras M. A., Spar I. L. High specific activity labeling of protein with I-131 by the iodine monochloride method. Proc Soc Exp Biol Med. 1966 Jun;122(2):407–414. doi: 10.3181/00379727-122-31148. [DOI] [PubMed] [Google Scholar]
  6. Barker W. C., Dayhoff M. O. Evolution of homologous physiological mechanisms based on protein sequence data. Comp Biochem Physiol B. 1979;62(1):1–5. doi: 10.1016/0305-0491(79)90002-6. [DOI] [PubMed] [Google Scholar]
  7. Bergman F., Damber M. G., Lindén U., Paul K. G. Mast cells and eosinophil granulocytes in the oestrogen-stimulated mouse uterus. Acta Endocrinol (Copenh) 1972 Jan;69(1):77–86. doi: 10.1530/acta.0.0690077. [DOI] [PubMed] [Google Scholar]
  8. Brody M. J., Edvinsson L., Sjöberg N. O. Preservation of estrogen-induced increase of uterine blood volume following catechlamine and mast cell histamine depletion. Proc Soc Exp Biol Med. 1975 May;149(1):120–123. doi: 10.3181/00379727-149-38756. [DOI] [PubMed] [Google Scholar]
  9. Clark K. E., Farley D. B., Van Orden D. E., Brody M. J. Estrogen-induced uterine hyperemia and edema persist during histamine receptor blockade. Proc Soc Exp Biol Med. 1977 Dec;156(3):411–416. doi: 10.3181/00379727-156-39947. [DOI] [PubMed] [Google Scholar]
  10. DAVIS M. E., HULIT B. E. Changes in circulating eosinophils in women during the menstrual cycle and reproduction. J Clin Endocrinol Metab. 1949 Aug;9(8):714–724. doi: 10.1210/jcem-9-8-714. [DOI] [PubMed] [Google Scholar]
  11. Dunnette S. L., Gleich G. J. Double-antibody radioimmunoassay for IgE. Methods Enzymol. 1981;73(Pt B):634–645. doi: 10.1016/0076-6879(81)73096-9. [DOI] [PubMed] [Google Scholar]
  12. Durack D. T., Ackerman S. J., Loegering D. A., Gleich G. J. Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5165–5169. doi: 10.1073/pnas.78.8.5165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Filley W. V., Holley K. E., Kephart G. M., Gleich G. J. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet. 1982 Jul 3;2(8288):11–16. doi: 10.1016/s0140-6736(82)91152-7. [DOI] [PubMed] [Google Scholar]
  14. Hales C. N., Woodhead J. S. Labeled antibodies and their use in the immunoradiometric assay. Methods Enzymol. 1980;70(A):334–355. doi: 10.1016/s0076-6879(80)70063-0. [DOI] [PubMed] [Google Scholar]
  15. KLEBANOFF S. J. INACTIVATION OF ESTROGEN BY RAT UTERINE PREPARATIONS. Endocrinology. 1965 Feb;76:301–311. doi: 10.1210/endo-76-2-301. [DOI] [PubMed] [Google Scholar]
  16. LUCAS F. V., NEUFELD H. A., UTTERBACK J. G., MARTIN A. P., STOTZ E. The effect of estrogen on the production of a peroxidase in the rat uterus. J Biol Chem. 1955 Jun;214(2):775–780. [PubMed] [Google Scholar]
  17. Lin T. M., Galbert S. P., Kiefer D., Spellacy W. N., Gall S. Characterization of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol. 1974 Jan 15;118(2):223–236. doi: 10.1016/0002-9378(74)90553-5. [DOI] [PubMed] [Google Scholar]
  18. Lobel B. L., Levy E., Kisch E. S., Shelesnyak M. C. Studies on the mechanism of nidation. 28. Experimental investigation on the origin of esosinophilic granulocytes in the uterus of the rat. Acta Endocrinol (Copenh) 1967 Jul;55(3):451–471. [PubMed] [Google Scholar]
  19. Marrs R. P., Mishell D. R., Jr Placental trophic hormones. Clin Obstet Gynecol. 1980 Sep;23(3):721–735. [PubMed] [Google Scholar]
  20. McConahey P. J., Dixon F. J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966;29(2):185–189. doi: 10.1159/000229699. [DOI] [PubMed] [Google Scholar]
  21. Olsson I., Venge P., Spitznagel J. K., Lehrer R. I. Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest. 1977 May;36(5):493–500. [PubMed] [Google Scholar]
  22. PATHAK C. L., KAHALI B. S. Cyclic variations in the eosinophil count during the phases of the menstrual cycle. J Clin Endocrinol Metab. 1957 Jul;17(7):862–869. doi: 10.1210/jcem-17-7-862. [DOI] [PubMed] [Google Scholar]
  23. RYTOMAA T. Organ distribution and histochemical properties of eosinophil granulocytes in rat. Acta Pathol Microbiol Scand Suppl. 1960;50(Suppl 140):1–118. [PubMed] [Google Scholar]
  24. Ross R., Klebanoff S. J. The eosinophilic leukocyte. Fine structure studies of changes in the uterus during the estrous cycle. J Exp Med. 1966 Oct 1;124(4):653–660. doi: 10.1084/jem.124.4.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tchernitchin A. Autoradiographic study of (6,7-3H)oestradiol-17 beta incorporation into rat uterus. Steroids. 1967 Dec;10(6):661–668. doi: 10.1016/0039-128x(67)90006-2. [DOI] [PubMed] [Google Scholar]
  26. Tchernitchin A. Fine structure of rat uterine eosinophils and the possible role of eosinophils in the mechanism of estrogen action. J Steroid Biochem. 1973 May;4(3):277–282. doi: 10.1016/0022-4731(73)90051-4. [DOI] [PubMed] [Google Scholar]
  27. Tchernitchin A., Hasbun J., Peña G., Vega S. Autoradiographic study of the in vitro uptake of estradiol by eosinophils in human endometrium. Proc Soc Exp Biol Med. 1971 May;137(1):108–110. doi: 10.3181/00379727-137-35523. [DOI] [PubMed] [Google Scholar]
  28. Tchernitchin A., Hasbun J., Peña G., Vega S. Autoradiographic study of the in vitro uptake of estradiol by eosinophils in human endometrium. Proc Soc Exp Biol Med. 1971 May;137(1):108–110. doi: 10.3181/00379727-137-35523. [DOI] [PubMed] [Google Scholar]
  29. Tchernitchin A. Radioautographic analysis of 6,7-3H estradiol-17beta uptake in rat uterus following extraction of endogenous estrogens. Steroids. 1970 Jun;15(6):799–808. doi: 10.1016/s0039-128x(70)80048-4. [DOI] [PubMed] [Google Scholar]
  30. Tchernitchin A. Radioautographic study of the effect of estradiol-17 , estrone, estriol, progesterone, testosterone and corticosterone on the in vitro uptake of 2,4,6,7- 3 H estradiol-17 by uterine eosinophils of the rat. Steroids. 1972 Apr;19(4):575–586. doi: 10.1016/s0039-128x(72)80023-0. [DOI] [PubMed] [Google Scholar]
  31. Tchernitchin A., Roorijck J., Tchernitchin X., Vandenhende J., Galand F. Dramatic early increase in uterine eosinophils after oestrogen administration. Nature. 1974 Mar 8;248(5444):142–143. doi: 10.1038/248142a0. [DOI] [PubMed] [Google Scholar]
  32. Tchernitchin A., Tchernitchin X., Galand P. Correlation of estrogen-induced uterine eosinophilia with other parameters of estrogen stimulation, produced with estradiol-17beta and estriol. Experientia. 1975 Aug 15;31(8):993–994. doi: 10.1007/BF02358897. [DOI] [PubMed] [Google Scholar]
  33. Vaitukaitis J. L., Braunstein G. D., Ross G. T. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol. 1972 Jul 15;113(6):751–758. doi: 10.1016/0002-9378(72)90553-4. [DOI] [PubMed] [Google Scholar]
  34. Venge P., Roxin L. E., Olsson I. Radioimmunoassay of human eosinophil cationic protein. Br J Haematol. 1977 Nov;37(3):331–335. doi: 10.1111/j.1365-2141.1977.tb01003.x. [DOI] [PubMed] [Google Scholar]
  35. Wassom D. L., Loegering D. A., Gleich G. J. Measurement of guinea pig eosinophil major basic protein by radioimmunoassay. Mol Immunol. 1979 Sep;16(9):711–719. doi: 10.1016/0161-5890(79)90012-9. [DOI] [PubMed] [Google Scholar]
  36. Wassom D. L., Loegering D. A., Solley G. O., Moore S. B., Schooley R. T., Fauci A. S., Gleich G. J. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest. 1981 Mar;67(3):651–661. doi: 10.1172/JCI110080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Weller P. F., Goetzl E. J., Austen K. F. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7440–7443. doi: 10.1073/pnas.77.12.7440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Yunginger J. W., Gleich G. J. Comparison of the protein-binding capacities of cyanogen bromide-activated polysaccharides. J Allergy Clin Immunol. 1972 Aug;50(2):109–116. doi: 10.1016/0091-6749(72)90006-1. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES